OPKO Health Inc OPK:NASDAQ

Last Price$1.87Cboe Real-Time Last Sale as of 2:32PM ET 8/23/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.08(4.36%)
Bid (Size)$1.86 (3,600)
Ask (Size)$1.87 (2,895)
Day Low / High$1.86 - 1.96
Volume1.6 M
 

View Biotechnology IndustryPeer Comparison as of 08/23/2019

 

OPKO Health Inc ( NASDAQ )

Price: $1.87
Change: -0.08 (4.36%)
Volume: 1.6 M
2:32PM ET 8/23/2019
 
 

Fate Therapeutics Inc ( NASDAQ )

Price: $17.40
Change: -1.02 (5.54%)
Volume: 306.3 K
2:29PM ET 8/23/2019
 
 

Momenta Pharmaceuticals Inc ( NASDAQ )

Price: $12.02
Change: -0.20 (1.64%)
Volume: 145.5 K
2:34PM ET 8/23/2019
 
 

Epizyme Inc ( NASDAQ )

Price: $12.86
Change: -0.42 (3.16%)
Volume: 154.2 K
2:33PM ET 8/23/2019
 
 

Veracyte Inc ( NASDAQ )

Price: $25.00
Change: -0.30 (1.19%)
Volume: 135.8 K
2:31PM ET 8/23/2019
 

Read more news Recent News

--Analyst Actions: OPKO Health's Price Target Cut to $4 From $5 at Barrington, Outperform Rating Reiterated
11:17AM ET 8/08/2019 MT Newswires

Price: 1.95, Change: -0.01, Percent Change: -0.26 ...

Insider Trends: Insider Purchase Adds to OPKO Health Positive Trend
7:15AM ET 7/17/2019 MT Newswires

Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, executed a purchase for 50,000 shares of OPKO Health (OPK) on Jul 16, 2019, for $105,981. ...

Insider Trends: Insider Buying Continued with Purchase of OPKO Health Stock
6:57AM ET 7/15/2019 MT Newswires

On Jul 12, 2019, Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, bought 50,000 shares in OPKO Health (OPK) for $107,788. Dr Frost has control...

Insider Trends: Insider Purchase of OPKO Health Stock Extends 90-Day Positive Trend
5:52PM ET 7/12/2019 MT Newswires

Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, executed a purchase for 100,000 shares of OPKO Health (OPK) on Jul 08, 2019, for $222,831. After...

View all Commentary and Analysis

OPKO Health, Inc. (OPK) CEO Phillip Frost on Q2 2019 Results - Earnings Call Transcript
9:31PM ET 8/07/2019 Seeking Alpha

Insider Weekends: Tracy Krohn Buys Shares Of W&T Offshore
11:55AM ET 7/23/2019 Seeking Alpha

Daily Insider Ratings Round Up 7/17/19
6:38AM ET 7/19/2019 Seeking Alpha

Daily Insider Ratings Round Up 7/15/19
11:30AM ET 7/17/2019 Seeking Alpha

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Phone+1.305.575.4100
Number of Employees5,690
Recent SEC Filing08/07/201910-Q
Chairman & Chief Executive OfficerPhillip Frost
Vice Chairman & Chief Technical OfficerJane H. Hsiao
Director & Executive Vice President-AdministrationSteven D. Rubin
Chief Executive Officer-OPKO RenalCharles W. Bishop

Company Highlights

Price Open$1.94
Previous Close$1.95
52 Week Range$1.73 - 6.16
Market Capitalization$1.1 B
Shares Outstanding615.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/08/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.39
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-26.54%
Return on Equity-13.86%

Analyst Ratings as of 03/14/2019

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset